神経痛治療の世界市場2020-2027:治療別(薬物、手術)、最終用途別(病院・診療所、外来手術センター)、地域別

◆英語タイトル:Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV023
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月7日
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、神経痛治療の世界市場について調査・分析し、調査範囲、調査手法、調査目的、エグゼクティブサマリー、産業概要、治療別市場規模(薬物、手術)、最終用途別市場規模(病院・診療所、外来手術センター)、地域別市場規模、競争分析などの項目を掲載しています。
・調査範囲
・調査手法
・調査目的
・エグゼクティブサマリー
・産業概要
・神経痛治療の世界市場規模:治療別(薬物、手術)
・神経痛治療の世界市場規模:最終用途別(病院・診療所、外来手術センター)
・神経痛治療の世界市場規模:地域別
・競争分析
【レポートの概要】

Neuralgia Treatment Market Growth & Trends

The global neuralgia treatment market size is expected to reach USD 2.8 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising geriatric population, increasing incidence of trigeminal neuralgia, and the growing prevalence of diabetes are the key factors driving the market. Neuralgia is a burning, stabbing, and severe pain due to a damaged or irritated nerve.

The chronic pain in the nerves can occur due to various factors such as infection, diabetes, aging, multiple sclerosis, or any similar disorders that damage the myelin sheath protecting certain nerves. Tumor compressing the trigeminal nerve can also cause the disorder. The prevalence of chronic pain in the trigeminal nerve increases with the aging population. According to the estimates published by the WHO, the geriatric population is anticipated to rise from 900.0 million in 2015 to 2.0 billion in 2050. The geriatric population is prone to many diseases such as diabetes and trigeminal neuralgia.

As per the American Association of Neuromuscular and Electrodiagnostic Medicine, the disorder usually affects the population aged 50 years or older. It also reported that women are more prone to trigeminal neuralgia than men. As per the study, The Patient’s Journey Through Trigeminal Neuralgia published by the International Association for The Study of Pain (IASP), the incidence rate of the disorder in the general population is 3.4 to 5.9 per 100,000 population. It also reported that the incidence rate is comparatively higher in the geriatric population. Such factors are expected to boost market growth over the forecast period. Stereotactic radiosurgery and microvascular decompression are the two most common procedures being adopted to treat the disorder.

Neuralgia Treatment Market Report Highlights

• On the basis of treatment, the surgery segment held the largest market share in 2019 owing to rising awareness regarding various treatment options and the high cost of surgeries

• The surgery segment has been further sub-segmented into Radiofrequency Thermal Lesioning, Stereotactic Radiosurgery, Microvascular Decompression, and others

• The ambulatory surgery center segment is anticipated to witness the fastest growth over the forecast period owing to the rising demand for a reduced hospital stay

• In North America, the market held the largest revenue share in 2019 owing to the presence of key players in the region.

【レポートの目次】

Table of Contents

Chapter 1 Report Scope
1.1 Market Segmentation and Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Research Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.2 Volume price analysis (Model 2)
2.7 List of Secondary Sources
Chapter 3 Objectives
3.1 Objective – 1
3.2 Objective – 2
3.3 Objective – 3
3.4 Objective – 4
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights
4.4 Market Snapshot
Chapter 5 Industry Outlook
5.1 Penetration & Growth Prospect Mapping
5.2 Regulatory Framework
5.3 Market Dynamics
5.3.1 Market driver analysis
5.3.1.1 Rising prevalence of trigeminal neuralgia
5.3.1.2 Increase in geriatric population across the globe
5.3.1.3 Increase in prevalence of diabetes
5.3.2 Market restraint analysis
5.3.2.1 High cost of surgery
5.4 Neuralgia Treatment Market Analysis Tools
5.4.1 SWOT Analysis, by PEST
5.4.2 Porter’s five forces analysis
Chapter 6 Neuralgia Treatment Market: Segment Analysis, By Treatment, 2016 – 2027 (USD Million)
6.1 Definitions & Scope
6.2 Treatment Market Share Analysis, 2019 & 2027
6.3 Neuralgia Treatment Market, by Treatment, 2016 to 2027
6.4 Market Size Forecasts and Trend Analysis
6.4.1Drug Based
6.4.1.1 Drug based market, 2016 – 2027 (USD Million)
6.4.1.2 Anticonvulsant Medicines
6.4.1.2.1 Anticonvulsant medicines market, 2016 – 2027 (USD Million)
6.4.1.3 Tricyclic antidepressants
6.4.1.3.1 Tricyclic antidepressantsmarket, 2016 – 2027 (USD Million)
6.4.2Surgery
6.4.2.1 Surgery market, 2016 – 2027 (USD Million)
6.4.2.2 Radiofrequency Thermal Lesioning
6.4.2.2.1 Radiofrequency thermal lesioning market, 2016 – 2027 (USD Million)
6.4.2.3 Stereotactic Radiosurgery
6.4.2.3.1 Stereotactic radiosurgerymarket, 2016 – 2027 (USD Million)
6.4.2.4 Microvascular Decompression
6.4.2.4.1 Microvascular decompressionmarket, 2016 – 2027 (USD Million)
6.4.2.5 Others
6.4.2.5.1 Others market, 2016 – 2027 (USD Million)
Chapter 7 Neuralgia Treatment Market: Segment Analysis, By End Use 2016 – 2027 (USD Million)
7.1 Definitions & Scope
7.2 End Use Market Share Analysis, 2019 & 2027
7.3 Neuralgia Treatment Market, by End Use, 2016 to 2027
7.4 Market Size Forecasts and Trend Analysis
7.4.1 Hospitals & Clinics
7.4.1.1 Hospitals & clinics market, 2016 – 2027 (USD Million)
7.4.2 Ambulatory Surgery Center
7.4.2.1 Ambulatory surgery centermarket, 2016 – 2027 (USD Million)
7.4.3 Others
7.4.3.1 Others market, 2016 – 2027 (USD Million)
Chapter 8 Neuralgia Treatment Market: Regional Market Analysis, By Treatment, and End Use, 2016 – 2027 (USD Million)
8.1 Definitions & Scope
8.2 Regional Market Share Analysis, 2019 & 2027
8.3 Regional Market Snapshot
8.4 Market Size Forecasts & Trend Analysis
8.4.1 North America
8.4.1.1 North America neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.1.2 The U.S.
8.4.1.2.1 The U.S. neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.1.3 Canada
8.4.1.3.1 Canada neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.2 Europe
8.4.2.1 Europe neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.2.2 The U.K.
8.4.2.2.1 The U.K. neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.2.3 Germany
8.4.2.3.1 Germany neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.3 Asia Pacific
8.4.3.1 Asia Pacific neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.3.2 Japan
8.4.3.2.1 Japan neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.3.3 China
8.4.3.3.1 China neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.4 Latin America
8.4.4.1 Latin America neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.4.2 Brazil
8.4.4.2.1 Brazil neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.4.3 Mexico
8.4.4.3.1 Mexico neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.5 Middle East & Africa
8.4.5.1 Middle East & Africa neuralgia treatmentmarket, 2016 – 2027 (USD Million)
8.4.5.2 South Africa
8.4.5.2.1 South Africa neuralgia treatment market, 2016 – 2027 (USD Million)
8.4.5.3 Saudi Arabia
8.4.5.3.1 Saudi Arabia neuralgia treatment market, 2016 – 2027 (USD Million)
Chapter 9 Neuralgia Treatment Market: Competitive Analysis
9.1 Company Profiles
9.1.1 GlaxoSmithKline PLC
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Pfizer Inc.
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Novartis AG
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.4 Biogen
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 Cadila Healthcare Limited
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Lundbeck Pharmaceuticals LLC
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives

List of Tables

Table 1 Primary interview details: North America
Table 2 Primary interview details: Europe
Table 3 Primary interview details: APAC
Table 4 Primary interview details: Latin America
Table 5 Primary interview details: MEA
Table 6 List of secondary sources
Table 7 List of abbreviation
Table 8 North America neuralgia treatment market, by country, 2016 - 2027 (USD Million)
Table 9 North America neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 10 North America neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 11 The U.S. neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 12 The U.S. neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 13 Canada neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 14 Canada neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 15 Europe neuralgia treatment market, by country, 2016 - 2027 (USD Million)
Table 16 Europe neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 17 Europe neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 18 The U.K. neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 19 The U.K. neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 20 Germany neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 21 Germany neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 22 Asia Pacific neuralgia treatment market, by country, 2016 - 2027 (USD Million)
Table 23 Asia Pacific neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 24 Asia Pacific neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 25 Japan neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 26 Japan neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 27 China neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 28 China neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 29 Latin America neuralgia treatment market, by country, 2016 - 2027 (USD Million)
Table 30 Latin America neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 31 Latin America neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 32 Brazil neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 33 Brazil neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 34 Mexico neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 35 Mexico neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 36 Middle East & Africa neuralgia treatment market, by country, 2016 - 2027 (USD Million)
Table 37 Middle East & Africa neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 38 Middle East & Africa neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 39 South Africa neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 40 South Africa neuralgia treatment market, by end use, 2016 - 2027 (USD Million)
Table 41 Saudi Arabia neuralgia treatment market, by treatment, 2016 - 2027 (USD Million)
Table 42 Saudi Arabia neuralgia treatment market, by end use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Neuralgia Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market summary (2019)
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Neuralgia treatment market: Treatment movement analysis
Fig. 16 Neuralgia treatment market treatment outlook: Key takeaways
Fig. 17 Drug based market, 2016 - 2027 (USD Million)
Fig. 18 Anticonvulsant medicines market, 2016 - 2027 (USD Million)
Fig. 19 Tricyclic antidepressants market, 2016 - 2027 (USD Million)
Fig. 20 Surgery market, 2016 - 2027 (USD Million)
Fig. 21 Radiofrequency thermal lesioning market, 2016 - 2027 (USD Million)
Fig. 22 Stereotactic Radiosurgery market, 2016 - 2027 (USD Million)
Fig. 22 Microvascular decompression market, 2016 - 2027 (USD Million)
Fig. 23 Others market, 2016 - 2027 (USD Million)
Fig. 24 Neuralgia treatment market: End Use movement analysis
Fig. 25 Neuralgia treatment market end use outlook: Key takeaways
Fig. 26 Hospitals& clinics market, 2016 - 2027 (USD Million)
Fig. 27 Ambulatory surgery center market, 2016 - 2027 (USD Million)
Fig. 28 Others market, 2016 - 2027 (USD Million)
Fig. 29 Regional Outlook, 2019 & 2027
Fig. 30 Regional market place: Key takeaways
Fig. 31 North America neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 32 The U.S. neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 33 Canada neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 34 Europe neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 35 The U.K. neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 36 Germany neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 37 Asia Pacific neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 38 Japan neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 39 China neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 40 Latin America neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 41 Brazil neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 42 Mexico neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 43 Middle East & Africa neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 44 South Africa neuralgia treatment market, 2016 - 2027 (USD Million)
Fig. 45 Saudi Arabia neuralgia treatment market, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[神経痛治療の世界市場2020-2027:治療別(薬物、手術)、最終用途別(病院・診療所、外来手術センター)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆